We conclude that future studies should aim to define specific isoform roles of JNK in cerebral I/R injury and neurodegenerative diseases and stratify brain tumor patients likely to benefit from JNK-targeted therapy. The gene discussed is MAPK8; the disease is brain neoplasm.